0001815708-25-000002.txt : 20251212 0001815708-25-000002.hdr.sgml : 20251212 20251212173047 ACCESSION NUMBER: 0001815708-25-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251212 DATE AS OF CHANGE: 20251212 EFFECTIVENESS DATE: 20251212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Telos Biotech Inc. CENTRAL INDEX KEY: 0001815708 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-566723 FILM NUMBER: 251569244 BUSINESS ADDRESS: STREET 1: 19 MORRIS AVENUE, BROOKLYN NAVY YARD STREET 2: BUILDING 128 CITY: BROOKLYN STATE: NY ZIP: 11205 BUSINESS PHONE: (516) 962-3186 MAIL ADDRESS: STREET 1: 19 MORRIS AVENUE, BROOKLYN NAVY YARD STREET 2: BUILDING 128 CITY: BROOKLYN STATE: NY ZIP: 11205 D 1 primary_doc.xml X0708 D LIVE 0001815708 Telos Biotech Inc. 3060 Pegasus Park Dr Building 6 Dallas TX TEXAS 75247 (469) 328-6859 DELAWARE None None Corporation true Mohammad Ehsan Sayed 3060 Pegasus Park Dr Building 6 Dallas TX TEXAS 75247 Executive Officer Director Enzo Tedone 3060 Pegasus Park Dr Building 6 Dallas TX TEXAS 75247 Executive Officer Director Jerry William Shay 3060 Pegasus Park Dr Building 6 Dallas TX TEXAS 75247 Executive Officer Sebastian Aguiar Brunemeier 3060 Pegasus Park Dr Building 6 Dallas TX TEXAS 75247 Director Biotechnology Decline to Disclose 06b false 2025-12-01 false true true false 0 2250000 724999 1525001 Stated "Total Offering Amount" and "Total Remaining to be Sold" each include the aggregate consideration the issuer may receive in the event the warrants offered are exercised for cash. Currently no warrants have been issued or exercised. false 4 0 0 0 false Telos Biotech Inc. Mohammad Sayed Mohammad Sayed Vice President 2025-12-12